Rialto Wealth Management’s Ginkgo Bioworks DNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-49
Closed -$486 – 1991
2026
Q2
$486 Sell
49
-5
-9% -$42 ﹤0.01% 1740
2026
Q1
$332 Buy
+54
New +$449 ﹤0.01% 1519

Other funds holding DNA

Rialto Wealth Management's DNA Position: Q3 2026 in Review

Rialto Wealth Management sold out of Ginkgo Bioworks (DNA) in Q3 2026, closing a stake of 49 shares — an estimated $486 sold.

Rialto Wealth Management first reported a position in DNA in Q1 2026 and held it in 2 quarters. The position peaked at $486 in Q2 2026. 185 funds tracked by Wall St. Rank hold DNA as of Q3 2026.

  • Rialto Wealth Management reported no remaining Ginkgo Bioworks position as of Q3 2026 after selling out during the quarter.
  • Rialto Wealth Management sold 49 Ginkgo Bioworks shares in Q3 2026, an estimated $486.
  • Rialto Wealth Management first reported a position in Ginkgo Bioworks in Q1 2026 and held it in 2 quarters.
  • Rialto Wealth Management's Ginkgo Bioworks position peaked at $486 in Q2 2026.
  • 185 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q3 2026.

Based on Rialto Wealth Management's 13F filing for Q3 2026, filed 16 Nov 2026.